Insulin resistance and pre-eclampsia: A role for tumor necrosis factor-α?

Gynecological Endocrinology

Volumn 18, Issue 3, 2004, Pages 117-123

  Anim Nyame, N ^a   Sooranna, S R ^a   Jones, J ^b   Alaghband Zadeh, J ^b   Steer, P J ^a   Johnson, M R ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Insulin; Insulin resistance; Insulin resistance index; Pre eclampsia; TNF

Indexed keywords

GLUCOSE; INSULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CALCULATION; CIRCULATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GESTATIONAL AGE; HUMAN; HYPOTHESIS; INSULIN RESISTANCE; MEASUREMENT; PLASMA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN FUNCTION; SAMPLE;

ADULT; BLOOD GLUCOSE; FASTING; FEMALE; GESTATIONAL AGE; HUMANS; INSULIN; INSULIN RESISTANCE; PRE-ECLAMPSIA; PREGNANCY; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1542327587     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590410001667832     Document Type: Article

References (41)

1. Lorentzen B, Birkeland KI, Endressen MJ, et al. Glucose intolerance in women in pre-eclampsia. Acta Obstet Gynecol Scand 1998;77:22-7
2. Martinez AE, Gonzalez OM, Quinones GA, et al. Hyperinsulinaemia in glucose intolerant women with pre-eclampsia. A case controlled study. Am J Hypertens 1996;9:610-14
3. Nisell H, Erikssen C, Persson B, et al. Is carbohydrate metabolism altered among women who have undergone pre-eclamptic pregnancy? Gynecol Obstet Inv 1999;48:241-6
4. Kaaja R, Laivuori H, Laakso M, et al. Evidence of a state of increased insulin resistance in pre-eclampsia. Metabolism 1999;48 892-6
5. Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinaemia 17 years after pre-eclamptic first pregnancy. J Clin Endocrin Metabol 1996;81:2908-11
6. Fuh MM, Yin CS, Pei D, et al. Resistance to insulin-mediated glucose uptake and hyperinsulinaemia in women who had pre-eclampsia during pregnancy. Am J Hypertens 1995;8:768-71
7. Chen CH, Lin KC, Tsai ST, et al. Different association of hypertension and insulin related metabolic syndrome between men and women in 8437 non-diabetic Chinese. Am J Hypertens 2000;13:846-53
8. Thomas GN, Tomlinson B, Chan JC, et al. An insulin receptor gene polymorphism is associated with diastolic blood pressure in Chinese subjects with components of the metabolic syndrome. Am J Hypertens 2000;13:745-52
9. Sowers JR, Saleh AA, Sokol RJ. Hyperinsulinemia and insulin resistance are associated with pre-eclampsia in African-Americans. Am J Hypertens 1995;8:1-4
10. Gans RO, Kraayenbrink AA, Van Geijn HP, et al. Insulin resistance characterises pregnant women that will develop pre-eclampsia. Presented at the meeting of the American Society of Hypertension XI, 1996;9(4): C14(Abstract)
11. Visser W, Beckmann I, Lim HL, et al. Bioactive tumour necrosis factor α in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol 1994;101:1081-2
12. Vince GL, Starkey PM, Ausrgulen R, et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995;102:20-5
13. Uysal KT, Wiesbrock SM, Marino MW, et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997;389: 610-14
14. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metabol 2000;11:212-17
15. Katsuki A, Sumida Y, Murashima S, et al. Serum levels of tumour necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metabol 1998;83:859-62
16. Bertin E, Nguyen P, Guenonou M, et al. Plasma levels of tumour necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metabol 2000;26:178-82
17. Anim-Nyame N, Sooranna PJ, Johnson MR, et al. Longitudinal study of resting peripheral blood flow in normal pregnancy and pregnancies complicated by chronic hypertension and pre-eclampsia. Cardiovasc Res 2001;50:603-9
18. National High Blood Pressure Educational Programme Working group on High Blood Pressure in Pregnancy. Report. Am J Obstet Gynecol 2000; 183:S1-S22
19. Watanabe N, Kamel S, Ohkubo A, et al. Urinary protein as measured with pyrogallol red-molybdate complex manually and in Hitachi 726 automated analyser. Clin Chem 1986;32:1551-4
20. Duncan MH, Singh BM, Wise PH, et al. A simple measure of insulin resistance. Lancet 346:1995;120-21
21. Cleland SJ, Petrie JR, Morris AD, et al. FIRI: a fair insulin resistance index? Lancet 1996;347:770
22. Matthews DR, Hosker JP, Rudenski JS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19
23. Bergman RN, Prager R, Volund A, et al. Equivalence of insulin sensitivity index in man derived by the minimal model method and euglycaemic glucose clamp. J Clin Invest 1987;79:790-800
24. Del Prato S, Pozzilli P. FIRI: fasting or false insulin resistance index? Lancet 1996;347:132
25. Catalano PM, Tyzbir ED, Roman NM, et al. Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am J Obstet Gynecol 1991;165:1667-72
26. Cousins L. Insulin sensitivity in pregnancy. Diabetes 1991;40(Suppl 2):39-43
27. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 2002.51:2207-13
28. Rowe JW, Young JB, Minaker KL, et al. Effect of insulin and glucose infusion on sympathetic nervous system activity in normal man. Diabetes 1981; 30:219-25
29. Redman CW, Sacks GP, Sargent IL. Pre-eclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506
30. Serin YS, Ozcelik B, Bapbuo M, et al. Predictive value of tumor necrosis factor alpha in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2002;100:143-5
31. Bullo M, Garcia-Lorda P, Peinado-Onsurbe J, et al. TNF-alpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipose LPL activity and leptin synthesis. Int J Obes Relat Metab Disord 2002;26:652-8
32. Baron AD, Laakso M, Brechtel G, et al. Mechanism of insulin resistance in IDDM: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metabol 1991;73:637-43
33. Anim-Nyame N, Sooranna SR, Johnson MR, et al. Resting peripheral blood flow in normal pregnancy and pre-eclampsia. Clin Sci 2000;99:505-10
34. Lorentzen B, Endresen MJ, Clausen T, et al. Fasting serum free fatty acid and triglycerides are increased before 20 weeks gestation in women who later develop pre-eclampsia. Hypertens Pregnancy 1994;13: 103-9
35. Lorentzen B, Drevon CA, Endresen MJ, et al. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and pre-eclamptic pregnancies. Br J Obstet Gynaecol 1995;102:530-7
36. Roberts JM, Taylor RN, Musci TJ, et al. Pre-eclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4
37. Laight DW, Carrier MJ, Anggard EE. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 2000;47:457-64
38. Pelikánova T, Kohout M, Válek J, et al. Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism 1989;38:188-92
39. Giudice LC, Martina NA, Crystal RA, et al. I. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe pre-eclampsia. Am J Obstet Gynecol 1997;176,751-7
40. Lewitt MS, Baxter RC. Insulin-like growth factor binding protein-1: a role for glucose counter regulation? Mol Cell Endocrinol 1991;79:C147-52
41. Lewitt MS, Denyer GS, Cooney GJ, et al. Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology 1991;129:2254-6